• Profile
Close

Survival results in biphasic malignant pleural mesothelioma patients: A multicentric analysis

The Journal of Thoracic and Cardiovascular Surgery Oct 11, 2019

Lococo F, Torricelli F, Lang-Lazdunski L, et al. - A large dataset of biphasic malignant pleural mesothelioma (Biph-MPM) cases was assessed in order to determine their prognostic factors and to assess the role of a multimodal approach, including cancer-directed surgery. Researchers assessed a total of 213 patients with Biph-MPM treated at 4 tertiary centers who experienced MPM; mean age: 68.4 ± 9.5 years; male/female ratio 5:1, respectively. In 58 patients (27.2%), a multimodal treatment including pleurectomy/decortication was performed, while 99 patients (46.5%) received chemotherapy alone, and 56 (26.3%) received best supportive care. Findings suggest that biphasic histology is associated with overall poor prognosis, however, improved long-term results could be achieved with a multimodal approach, including cancer-directed surgery, in very selected patients with Biph-MPM.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay